Medicus Pharma: Prostate Cancer Breakthrough Tevevelix FDA Study Greenlit

By Proactive Investors / February 13, 2026 / www.youtube.com / Article Link

Medicus Pharma Ltd has received FDA clearance to launch a Phase 2b study of Teverelix(R) in advanced prostate cancer.

Recent News

Minera Alamos expects major near-term rise in production

June 01, 2026 / www.canadianminingreport.com

Gold stocks up on rising metals price, equities

June 01, 2026 / www.canadianminingreport.com

Gold stocks drop as equities mixed

May 25, 2026 / www.canadianminingreport.com

Copper and zinc strong, but outpaced in 2026 by tungsten surge

May 25, 2026 / www.canadianminingreport.com

Barrick completes Q1/26 reporting season for Big Gold

May 18, 2026 / www.canadianminingreport.com

See all >